IP Library Granted Patent US 10,556,005
Granted Patent B2
US 10,556,005 · App. 15/168,839 · Granted Feb 11, 2020

Adjuvant composition containing citrulline

Inventors: Chikateru Nozaki (Kumamoto, JP); Kazuyoshi Kaminaka (Kumamoto, JP); Junichi Matsuda (Kumamoto, JP)
Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
A61K39/39A61K39/0007A61K39/12A61K39/145A61K2039/55511A61K2039/55516A61K2039/575C12N2760/16134C12N2760/16171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,556,005
App. No.
15/168,839
Granted
Feb 11, 2020
Kind
B2
Abstract

A novel adjuvant composition is provided that is excellent in safety and convenience as compared to the conventional adjuvant such as Alum. An adjuvant composition comprising citrullines, which are water soluble substance present in the living body, and/or a salt thereof; a vaccine composition comprising said adjuvant composition and an antigen; a process for preparing said adjuvant composition and said vaccine composition; and a method for administering said adjuvant composition and said vaccine composition are provided.

Claims (2)

1. A process for enhancing the immunogenicity of an antigen comprising adding an adjuvant effective amount of citrulline to a vaccine comprising said antigen, wherein the adjuvant effective amount of citrulline ranges from 1 mg/mL to 50 mg/mL, wherein the citrulline is at least one member selected from the group consisting of L-citrulline, D-citrulline, L-thiocitrulline, L-thiohomocitrulline, S-methyl-L-thio-citrulline and S-ethyl-L-thiocitrulline.

2. A vaccine composition comprising an adjuvant effective amount of citrulline and an antigen, wherein the adjuvant effective amount of citrulline ranges from 1 mg/mL to 50 mg/mL, wherein the citrulline is at least one member selected from the group consisting of L-citrulline, D-citrulline, L-thiocitrulline, L-thiohomocitrulline, S-methyl-L-thio-citrulline and S-ethyl-L-thiocitrulline.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: KM BIOLOGICS CO., LTD.
Reel/Frame 051520/0971 →
CHANGE OF ADDRESS OF ASSIGNEE Recorded Apr 15, 2019
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 050169/0778 →